What is the risk of developing parkinsonism following neuroleptic use?

Neurology

Volumn 66, Issue 6, 2006, Pages 941-943

  Noyes, Katia ^a   Liu, Hangsheng ^a   Holloway, Robert G ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; NEUROLEPTIC AGENT;

AGE; AGED; ARTICLE; DISABILITY; DRUG INDUCED DISEASE; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MULTIVARIATE ANALYSIS; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; STATISTICAL MODEL; STATISTICS;

AGED; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MEDICARE; PARKINSONIAN DISORDERS; RISK FACTORS;

EID: 33645829046     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000203348.13337.89     Document Type: Article

References (10)

1. Currier GW, Allen MH, Bunney EB, et al. Novel therapies for treating acute agitation. J Emerg Med 2004;27(4 suppl):S13-S18.
2. Lee PE, Gill SS, Freedman M, Bronskill SE, Hillmer MP, Rochon PA. Atypical antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia: systematic review. BMJ 2004;329:75-79.
3. Avorn J, Bohn RL, Mogun H, et al. Neuroleptic drug exposure and treatment of Parkinsonism in the elderly: a case-control study. Am J Med 1995;99:48-54.
4. Kalish SC, Bohn RL, Mogun H, Glynn RJ, Gurwitz JH, Avorn J. Antipsychotic prescribing patterns and the treatment of extrapyramidal symptoms in older people. J Am Geriatr Soc 1995;43:967-973.
5. Lapane KL, Fernandez HH, Friedman JH. Prevalence, clinical characteristics, and pharmacologic treatment of Parkinson's disease in residents in long-term care facilities. SAGE Study Group. Pharmacotherapy 1999;19:1321-1327.
6. Simon SR, Chan KA, Soumerai SB, et al. Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc 2005;53:227-232.
7. Adler GS. A profile of the Medicare Current Beneficiary Survey. Health Care Financ Rev 1994;15:153-163.
8. Noyes K, Liu H, Li Y, Holloway RG, Dick AW. Economic burden associated with Parkinson's disease on elder Medicare beneficiaries. Mov Disord 2005; Oct 6 [Epub ahead of print].
9. Strickland D, Bertoni JM. Parkinson's prevalence estimated by a state registry. Mov Disord 2004;19:318-323.
10. Marder K, Levy G, Louis ED, et al. Accuracy of family history data on Parkinson's disease. Neurology 2003;61:18-23.